6-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April, 2024

Commission File Number 001-37928

ChipMOS TECHNOLOGIES INC.

(Translation of Registrant’s Name Into English)

No. 1, R&D Rd. 1, Hsinchu Science Park

Hsinchu, Taiwan

Republic of China

(Address of Principal Executive Offices)

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

 

 

 

Dated: April 30, 2024

 

ChipMOS TECHNOLOGIES INC.

        (Registrant)

 

 

 

 

 

 

By:

/S/ S. J. Cheng

 

 

Name:

S. J. Cheng

 

 

Title:

Chairman & President

 

 

 


 

 

Below is the English version of our April 30, 2024 TWSE MOPS filing.

 

Date of announcement: 2024/04/30

Subject: Announcement of the Board meeting date for the Company’s 2024 first quarter consolidated financial statements.

Date of events: 2024/04/30

To which item it meets: Article 4, Paragraph 1, Item 31 of the Taiwan Stock Exchange Corporation Procedures for Verification and Disclosure of Material Information of Companies with Listed Securities

Statement:

1.
Date of a notice of the board of directors meeting is issued: 2024/04/30
2.
Expected date of the board of directors meeting is convened: 2024/05/09
3.
Expected year and quarter of the financial reports or the annual self-assessed financial information submitted to the board of directors or approved by the board of directors: The Company’s 2024 first quarter consolidated financial statements.
4.
Any other matters that need to be specified: None.